Growth Metrics

Exact Sciences (EXAS) Income from Continuing Operations: 2009-2024

Historic Income from Continuing Operations for Exact Sciences (EXAS) over the last 16 years, with Dec 2024 value amounting to -$1.0 billion.

  • Exact Sciences' Income from Continuing Operations rose 48.76% to -$19.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$986.6 million, marking a year-over-year decrease of 360.86%. This contributed to the annual value of -$1.0 billion for FY2024, which is 403.97% down from last year.
  • Per Exact Sciences' latest filing, its Income from Continuing Operations stood at -$1.0 billion for FY2024, which was down 403.97% from -$204.1 million recorded in FY2023.
  • In the past 5 years, Exact Sciences' Income from Continuing Operations ranged from a high of -$204.1 million in FY2023 and a low of -$1.0 billion during FY2024.
  • In the last 3 years, Exact Sciences' Income from Continuing Operations had a median value of -$623.5 million in 2022 and averaged -$618.8 million.
  • Per our database at Business Quant, Exact Sciences' Income from Continuing Operations spiked by 67.26% in 2023 and then slumped by 403.97% in 2024.
  • Yearly analysis of 5 years shows Exact Sciences' Income from Continuing Operations stood at -$823.6 million in 2020, then increased by 27.68% to -$595.6 million in 2021, then declined by 4.68% to -$623.5 million in 2022, then surged by 67.26% to -$204.1 million in 2023, then crashed by 403.97% to -$1.0 billion in 2024.